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Abstract
Background: Ocular albinism type 1, an X-linked disease characterized by the presence of enlarged melanosomes in the
retinal pigment epithelium (RPE) and abnormal crossing of axons at the optic chiasm, is caused by mutations in the OA1
gene. The protein product of this gene is a G-protein-coupled receptor (GPCR) localized in RPE melanosomes. The Oa1-/-
mouse model of ocular albinism reproduces the human disease. Oa1 has been shown to immunoprecipitate with the Gai
subunit of heterotrimeric G proteins from human skin melanocytes. However, the Gai subfamily has three highly
homologous members, Gai1, Gai2 and Gai3 and it is possible that one or more of them partners with Oa1. We had
previously shown by in-vivo studies that Gai3-/- and Oa1-/- mice have similar RPE phenotype and decussation patterns. In
this paper we analyze the specificity of the Oa1-Gai interaction.
Methodology: By using the genetic mouse models Gai1-/-, Gai2-/-, Gai3-/- and the double knockout Gai1-/-, Gai3-/- that lack
functional Gai1, Gai2, Gai3, or both Gai1 and Gai3 proteins, respectively, we show that Gai3 is critical for the maintenance
of a normal melanosomal phenotype and that its absence is associated with changes in melanosomal size and density. GST-
pull-down and immunoprecipitation assays conclusively demonstrate that Gai3 is the only Gai that binds to Oa1. Western
blots show that Gai3 expression is barely detectable in the Oa1-/- RPE, strongly supporting a previously unsuspected role for
Gai3 in melanosomal biogenesis.
Conclusion: Our results identify the Oa1 transducer Gai3 as the first downstream component in the Oa1 signaling pathway.
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Introduction
Hypopigmentation mutations affecting melanin synthesis or
melanosomal biogenesis in the retinal pigment epithelium (RPE) of
mammals are known to have profound effects on the developing
retina and visual pathways, including abnormal crossing of the
optic axons, nystagmus, strabismus, foveal hypoplasia, and
reduced visual acuity [1]. Two forms of albinism are commonly
recognized: oculocutaneous albinism (OCA), in which neither the
eye nor the skin or hair are pigmented and ocular albinism (OA),
which affects primarily the eye pigmentation.
Ocular albinism type 1 (OA1, also called Nettleship-Falls type), is
the most common form of ocular albinism. It has an estimated
prevalence of 1/50,000 in the general population of the United
States [2]. Although the cutaneous manifestations of OA1 are very
mild, affected patients present abnormal macromelanosomes in
both the RPE and skin [3]. In contrast to other forms of albinism,
melanin is not dramatically reduced in OA1; in fact, this disease is
characterized by the unusual coexistence of the typical albino
visual defects with a substantial amount of melanin in the eyes [4].
Different types of mutations in the OA1 gene have been associated
with ocular albinism type 1 (http://albinismdb.med.umn.edu/
oa1mut.html#mutations). OA1, the protein product of the OA1
gene, is a G protein-coupled receptor localized to RPE
melanosomal membranes and the initiator of the observed
abnormal visual phenotype in ocular albinism. The position of
OA1 within these membranes, with its N-terminal towards the
lumen of the melanosome and C-terminal towards the cytoplasm,
suggests that it may function as a novel intracellular GPCR
activated by the binding of a melanosomal ligand. This ligand
could thus regulate melanosomal biogenesis through activation of
specific G-proteins found in the RPE cytoplasm [5]. In addition,
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24376this localization of OA1 is consistent with its proposed role as a
stop signal for melanosome overgrowth during melanogenesis
[6,7] and could explain the changes in RPE phenotype observed in
ocular albinism: mutations or deletions in OA1 producing a non
functional OA1 protein would allow a continuous vesicular traffic
of membrane proteins to melanosomes resulting in the formation
of macromelanosomes [3].
It has been shown that the endogenous OA1 from human
melanocyte extracts co-immunoprecipitates mainly with the alpha
subunits of the Gi subfamily of heterotrimeric G-proteins [8]. The
Gai subfamily comprises three closely related members, Gai1,
Gai2, and Gai3, which share 85 to 95% amino acid sequence
identity and partial overlapping expression patterns. In addition to
their established function in signal transduction across the plasma
membrane, these heterotrimeric Gi proteins localize to intracel-
lular membranes and have been implicated in the regulation of
membrane trafficking and fusion events along the secretory and
endocytic pathways, such as vesicle formation by the endoplasmic
reticulum, the Golgi/secretory pathway, and vesicle trafficking
and fusion [9,10,11]. We have recently shown that mouse Oa1
and Gai3 play an important role in the determination of
melanosomal size and density and that both signal in the same
pathway to regulate axonal guidance at the optic chiasm [12]. In
the present study, we used Gai knockout mouse models to
investigate whether the other two members of the Gai family of
proteins, Gai1 and Gai2, are involved in the regulation of size and
density of the RPE melanosomes. We also studied the effects of the
loss of both Gai1 and Gai3 using the corresponding double
knockout mice (heretofore called DKO). In addition, we analyzed
the specific interaction of each Gai protein with Oa1 in in-vitro
immunoprecipitation and GST-pull-down experiments. For the
latter, two polypeptides corresponding to the Oa1 third intracel-
lular loop (i3) and carboxy-terminal tail (CT), the two regions that
have been shown to play a critical role as selectivity determinants
in receptor–G-protein interactions [13,14], were tested. Further-
more, we investigated the expression and cellular response of Gai
proteins in the RPE of Oa1-/- mice using Western blots and ADP-
ribosylation. Altogether, our in-vivo and in-vitro data demonstrate a
previously unknown role of Gai3 as the specific protein
downstream of Oa1 that regulates the size and density of RPE
melanosomes.
Results
Size, density and morphology of RPE melanosomes
To investigate the involvement of Gai proteins in the regulation
of size and density of RPE melanosomes, we analyzed electron-
micrographs of RPE melanosomes from each Gai1-/-, Gai2-/-,
Gai3-/- and DKO mice, using 129 Sv wild-type mice as controls,
as discussed in Materials and Methods. We had previously shown
that Gai3-/- mice, like Oa1-/- mice, have larger RPE melano-
somes than those of control mice, and that they each have reduced
density of melanosomes [12] (Figures 1A, B, C and D). Notably,
the two background strains for these knock-out mice (129 Sv and
C57Bl/6NCrl, hereafter B6/NCrl) differ substantially in melano-
some size and density, making clear the need for appropriate
controls when considering these features of the RPE. Oa1-/-
macromelanosomes are conspicuously larger than Gai3-/- macro-
melanosomes, but the latter are still significantly larger than those
found in the 129 Sv control mice [12]. Our current electron
microscopy results compare the relative roles of Gai1 and Gai2 to
that of Gai3 upon melanosomal size, density and shape, and assess
the effects of combining the loss of two of them in a double
knockout mouse.
We first examined the size of melanosomes in the RPE of these
different Gai knockout mice. The RPE of Gai1-/- mice shows
melanosomes that appear slightly enlarged (Figure 1E), while
melanosomes in Gai2-/- mice appear no different (Figure 1F),
when compared with the melanosomes of 129 Sv mice (Figure 1C).
By contrast, the RPE in DKO mice appears to contain enlarged
melanosomes relative to those in 129 Sv mice, being comparable
in size to those in the RPE of Gai3-/- mice (Figure 1D). In order to
quantify these differences, we measured melanosomal size, and
determined the relative frequency of larger, macro-melanosomes
(.5000 nm
2) within the RPE of the different Gai-/- mice. A total
of 2501 129 Sv, 1285 Gai1-/-, 1609 Gai2-/-, 1115 Gai3-/- and
1997 DKO melanosomes were sampled.
Figure 1. Appearance of RPE melanosomes from Gai1-/-, Gai2-/- and DKO Gai1-/-, Gai3-/- mice. RPEs from Oa1-/- (B) and their control B6/
NCrl (A) mice and Gai3-/- (D) and their control 129 Sv (C) mice have been published before [12] and are shown for comparison. The ultrathin RPE
sections show that Gai1-/- (E) and Gai2 -/- (F) mice do not have macromelanosomes as those present in Oa1-/- (B), Gai3-/- (D) and DKO Gai1-/-, Gai3-/-
(G) mice. Electron micrographs of ultrathin sections, 16,0006magnification; scale bars for all micrographs, 01 mm, is shown only in (F).
doi:10.1371/journal.pone.0024376.g001
Gai3 Interacts with Oa1 G-Protein Coupled Receptor
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24376Comparison of the area of melanosomes from each mouse line
(Figure 2A) shows that the frequency of larger melanosomes
significantly differs between the groups, (ANOVA, p,0.05).
Gai3-/- RPEs have the highest percentage of melanosomes larger
than 5000 nm
2 (6.58%61.47), and post-hoc Tukey tests confirmed
that this group is significantly larger than the 129 Sv control retinas
(p,0.05).Thus,lossofonlyGai3yieldedasignificantincreaseinthe
presence of larger melanosomes. Combining the loss of Gai1 with
Gai3 proteins in the DKO mice certainly did not worsen the
abnormal morphology of the Gai3-/- RPE melanosomes. Together,
these results suggest that only Gai3 has a function in the
determination of the size of these organelles.
Second, we evaluated melanosome density (number of melano-
somes/RPE mm
2) in the RPE of all the Gai-/- and their 129 Sv
control mice (Figure 2B). While melanosomal density need not be
inversely related to melanosome size, we previously found that it
was in both Gai3-/- and in Oa1-/- mice [12], and so extended
these analyses to the present knock-out mice. Gai1-/- and Gai2-/-
mice showed comparable densities to those of 129 Sv mice, while
Gai3-/- mice had a large reduction (37.3%) in melanosomal
density when compared to 129 Sv mice. DKO mice also showed a
comparable effect (a 34.6% reduction). Statistical analysis
confirmed an effect of group (ANOVA, p,0.05), and post-hoc
Tukey tests confirmed that Gai3-/- and DKO are significantly
different from both 129 Sv and Gai2-/- mice (p,0.05). These
results and the fact that the loss of Gai1 alone had no significant
effect on either melanosome size or density leads us to conclude
that of the three heterotrimeric Gai proteins, Gai3 may be the
endogenous downstream protein in the Oa1 signaling cascade that
controls melanosomal size and density.
Third, we compared the morphology of the melanosomes in the
RPE of the different Gai-/- mice with that of their control mice,
129 Sv, to determine the percentage of melanosomes with a round
shape. We classified all melanosomes according to their sphericity
level, as described in Materials and Methods. Comparisons of
129 Sv with each Gai-/- mouse studied showed that all animals
except for Gai2-/- have a similar percentage of RPE melanosomes
that are round: 129 Sv 8.75%60.25, Gai1-/- 9.37%60.77,
Gai2-/- 5.39%60.37, Gai3-/- 9.12%61.85, and DKO
7.65%60.31. One-way analysis of variance, however, failed to
reveal any effect of group despite the appearance of fewer round
melanosomes in Gai2-/- (Figure 2C).
Figure 2. RPE melanosomal size, density and morphology of all Gai-/- mice compared to control 129 Sv mice. (A) Percentage of
melanosomes larger than 5000 nm
2 in each of the mouse lines analyzed. The Gai3-/- mice have the highest percentage of melanosomes larger than
5000 nm
2 in the RPE. (B) Mean density of melanosomes: The Gai3-/- group had the lowest mean number of melanosomes per RPE area (5965.2), and
the wild-type and Gai2-/- groups had the largest mean density of melanosomes (96.868.2 and 93.468.1, respectively). (C) Percentage of round
melanosomes: The Gai1-/- and Gai3-/- groups have the larger number of round melanosomes (9.3760.77 and 9.1261.85 respectively), followed by
the 129 Sv wild-type (8.75%60.25), DKO (7.65%60.31) and Gai2-/- (5.39%60.37).
doi:10.1371/journal.pone.0024376.g002
Gai3 Interacts with Oa1 G-Protein Coupled Receptor
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24376Analysis of retinal function in all Gai-/- mice by
electroretinography
ERG responses obtained from129 Sv, Gai1-/-, Gai3-/- and
DKO mice are summarized in Figure 3A and from 129 Sv and
Gai2-/- mice in Figure 3B. In each panel, mean response
amplitudes (61sd) are plotted against stimulus intensity (left to
right). The retinal function of Gai1-/-, Gai3-/- and DKO mice, as
judged by the electroretinograms, appears to be not significantly
different and within normal limits from control retinas (Figure 3A).
Curiously, the ERGs of the Gai2-/- mice show a reduced b-wave
amplitude (Figure 3B), suggesting that the lack of Gai2 had some
other impact on rod-mediated, but not on cone-mediated, retinal
function, but the reason for this difference is not yet understood.
The Gai3 protein specifically interacts with the
melanosomal GPCR Oa1
Seven transmembrane GPCRs are characterized by their ability
to couple with and activate heterotrimeric G proteins in response
to a ligand binding mainly through two well-known functional
regions: the third intracellular loop (i3) and the carboxy-terminal
tail (CT) [8,14]. Given that Oa1 shares all typical hallmarks of
GPCRs, to characterize the potential interactions of Oa1 and
Gai3 we carried out in-vitro binding studies in which recombinant
fusion polypeptides of glutathione S-transferase with i3 and CT
regions of Oa1, immobilized on glutathione-agarose beads, were
incubated with in-vitro-synthesized
35S-labeled Ga proteins.
Figure 4A shows a diagram indicating how the GST fusion
proteins were obtained using the PGEXT4-2 vector, as detailed in
Material and Methods. Figure 4B corroborates that the apparent
molecular masses of the fusion proteins, after SDS-PAGE
electrophoresis, correspond to the expected 29 kDa for the
GST::Oa1-i3 fusion protein and 37 kDa for the GST::Oa1–CT
fusion protein; and Figure 4C shows the apparent molecular
masses of the in-vitro synthesized
35S-labeled Ga proteins.
SDS-PAGE of the Oa1- Gai interacting complexes eluted from
the agarose beads and Coomassie blue staining of the gel showed
that each lane contained the same amount of GST-fusion protein:
lanes 2–7 and 8–13 correspond to GST::Oa1-CT and GST::Oa1-
i3 reactions, respectively (Figure 4D). Interestingly, the autoradio-
graph of the same gel demonstrated that Gai3 is the only one of all
Ga proteins tested that specifically binds to Oa1 (Figure 4E, lanes
4 and 10). No binding was detected when GST::Oa1-i3 and
GST::Oa1-CT were incubated with
35S-labeled Gai1, Gai2, Gas,
or Gaq or when GST alone, used as control, was incubated with
one of the
35S-labeled Ga proteins (we used Gai3). Also, incubation
of beads having only GST-fusion proteins (negative control) did
not show any non-specific Oa1 binding with TNT rabbit
retinoculocyte lysate or with the beads (Figure 4E, lanes 7 and 13).
Mass spectrometry also identifies Gai3 as the specific
OA1-interacting Gai protein
To identify RPE proteins that interact with human OA1 and
gain a better understanding of this GPCR’s function, we used a
human antibody against OA1 in immunoprecipitation (IP)
reactions followed by SDS-PAGE. For these experiments, we
dissected the RPE from donor, adult human eyes, which allowed
us to obtain sufficient amount of protein. Half of the gel was
stained with Coomassie blue to visualize the protein bands. Bands
in the appropriate molecular mass of Gai proteins (39–41 kDa)
and OA1 (45–48 kDa) were excised, destained, trypsinized and
sent for mass spectrometry analysis to the Pasarow Mass
Spectrometry core facility at UCLA. The other half of the gel
was transferred to nitrocellulose membranes to confirm by
Western blot analysis, using antibodies to the mass spectrometry-
identified interacting protein, the specificity of the OA1 partner.
As we anticipated, mass spectrometry of the ,38–41 kDa
excised band identified Gai3 as one of the proteins immunopre-
cipitated together with OA1 (Table 1). We corroborated the
Figure 3. Representative ERG responses of Gai1-/-, Gai2-/-, Gai3-/- and DKO mice. Standardized ERG was performed in experimental and
control mice in two different sessions. A) ERGs from wild-type, Gai1-/-, Gai3-/- and DKO mice. B) ERGs from wild-type and Gai2-/- mice.
doi:10.1371/journal.pone.0024376.g003
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anti-Gai3 antibody and visualizing the Gai3 band using the ECL
detection system (Figure 5A). Given that the commercially
available antibodies against Gai3 recognize both, Gai3 and Gb,
Gb was another protein immunoprecipitated together with OA1
and identified by mass spectrometry (Table 1). RPE lysates not
immunoprecipitated with antibodies against OA1 but incubated
with pre-immune serum did not show any G-protein on the
corresponding lane of the blot (Figure 5A). Further confirmation of
the OA1 and Gai3 interaction was obtained by performing a
reciprocal IP experiment using lysates containing proteins of adult,
human RPE and the anti-Gai3 antibody. After separating the
immunoprecipitated proteins by SDS-PAGE and transferring
them to nitrocellulose membranes, the blot was incubated with the
anti-OA1 antibody. Our results show the presence of two forms of
OA1, previously described with apparent molecular weights of 45
and 48 kDa [15], in the lane corresponding to the RPE proteins
immunoprecipitated with the anti-Gai3 antibody and the absence
of the OA1 protein in the lane corresponding to the RPE lysates
incubated with pre-immune serum (Figure 5B).
Gai3 compensates the lack of Gai1 in Gai1-/- mouse RPE
Compensatory increases elevating a Gai subunit level in a tissue
when another Gai subunit is missing from it have been previously
observed [16].To test this possibility, we used Western blots
incubated with Gaicommon antibody to analyze the expression of
Figure 4. Analysis of interactions between Oa1 and heterotrimeric Ga proteins by in- vitro pull-down assay. A) Schematic
representation of the vector used to make the GST-fusion polypeptides GST::Oa1-i3 and GST::Oa1-CT. Each amplified Oa1 sequence (i3 and CT) was
cloned into the PGEXT4-2 vector containing GST between the selected restriction enzymes (BamH I and Sal I). B) Coomassie-blue stained gel showing
the SDS-PAGE-separated fusion proteins used in the pull-down experiment. GST by itself has an apparent molecular weight of 26 kDa, the GST::Oa1-i3
fusion protein of 29 kDa and the GST::Oa1-CT fusion protein of 37 kDa in agreement with their estimated molecular masses. C) Autoradiogram of in-
vitro transcribed and translated
35S-labeled Ga proteins that will be tested for Oa1 binding activity below (D–E), after separation by SDS-PAGE on a
10% Tris-Glycine polyacrylamide gel (D–E). The apparent molecular weight of each Ga protein is in agreement with its predicted molecular mass,
Gai1: 41 kDa, Gai2: 40 kDa, Gai3: 41 kDa, Gaq: 42 kDa, Gas: 46 kDa and luciferase, run as a control: 61 kDa. D) Commassie blue staining of the gel
used for SDS-PAGE of recombinant GST::Oa1-CT and GST::Oa1-i3 fusion proteins immobilized on glutathione-agarose beads and incubated with the
indicated
35S-labeled Ga proteins. Lanes 1 and 14 had the GST protein incubated with one of the
35S-labeled Ga proteins in this experiment,
35S-Gai3.
Lanes 2–7: GST::Oa1-CT incubated with the indicated
35S-labeled Ga. Lanes 8–13: GST::Oa1-i3 incubated with the indicated
35S-Ga. Since the amount
of
35S-Ga protein is minimal, only the fusion proteins are observed in this gel. Lanes 7 and 13: GST-fusion proteins immobilized on glutathione-
agarose beads (Neg. C: negative control). All lanes with the same fusion protein have comparable amounts of protein. E) Autoradiograph of the same
gel showing that of all
35S-labeled Ga proteins, Gai3 is the only one that binds specifically to Oa1(lanes 4 and 10). Molecular weight markers are
expressed in kDa.
doi:10.1371/journal.pone.0024376.g004
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Gai1-/-, Gai2-/-, Gai3-/-, DKO and 129 Sv mice. The relative
amount of protein in each band was then measured by
densitometry. On the Western blot, Gai1 and Gai3 run together
as one band at 41 kDa. In the absence of Gai1 (in Gai1-/- mice),
levels of Gai3 much higher than those in wild-type RPE are
observed (Figure 6, lanes 1 and 5, respectively) since the
corresponding band from the 129 Sv RPE has both Gai1 and
Gai3. Densitometry measurements (Figure 6B) confirm this,
showing 3.860.7 optical density (OD) units for Gai3 in lane 1
(Gai1-/- RPE) and 3.660.3 for both Gai1 and Gai3 in lane 5
(129 Sv RPE). Gai2 is also higher in Gai1-/- RPE than in control
RPE. In the case of Gai3-/- mice, it is not possible to determine if
a small increase in Gai1 is present in its RPE, since we do not
exactly know how much Gai1 or Gai3 is present in the
corresponding band from the 129 Sv RPE; the levels of Gai2
are comparable in these animals to those of control RPE. In
contrast, absence of Gai2 in the Gai2-/- mice is accompanied by a
reduced level of the 41 kDa band corresponding to the Gai1 and
Gai3 proteins, and loss of both Gai1 and Gai3 in the DKO mice
does not trigger an up-regulation of Gai2 levels (Figures 6, A and
B). These results suggest that at the protein level, Gai3 may
compensate completely for the loss of Gai1 in the Gai1-/- mice
and that Gai1 may compensate only partially, if it does so, for the
loss of Gai3 in Gai3-/- mice.
Gai3 may be absent or expressed at very low levels in the
RPE of Oa1-/- mice
To get more insight into the Oa1 signaling cascade, we tested
the functional expression of Gai1, Gai2 and Gai3 in the RPE of
Oa1-/- mice and their congenic controls, C57Bl/NCrl mice, by
performing Pertussis toxin (PTX)-mediated
32P-ADP ribosylation
Table 1. Gai3 is identified by LC-MS/MS as the specific Gai protein interacting with OA1.
Accession no. Entry Description Mascot score MW
Unique peptides
matched
NP_006487 Guanine nucleotide binding
protein (G protein), alpha
inhibiting activity polypeptide3
(Gai-3) [Homo sapiens]
Association with Golgi-derived
vesicles and protein trafficking
[31]
63 41076 4
NP_0020661 G protein beta subunit [Homo
sapiens]
Proteins that cover a wide variety
of functions in signal
transduction, pre-mRNA
processing and cytoskeleton
assembly [32].
234 38061
Mascot search (Matrix Science) identified both, Gai3 and Gb in the immunoprecipitate of adult human RPE with the OA1 antibody. The entry names and accession
numbers (UniProtKB) in this Table are provided along with a brief description of the function of the proteins and the match score, as well as the number of unique
peptides found by nLC–MSMS for each protein.
doi:10.1371/journal.pone.0024376.t001
Figure 5. Gai3 is the specific Oa1-interacting protein. A) Western blot of proteins from human RPE immunoprecipitated with the anti-OA1
antibody as described in Materials and Methods. SDS–PAGE was followed by incubation with anti-Gai3 antibodies. Left lane: RPE extract incubated
with OA1 antibody; right lane: RPE extract incubated with pre-immune serum. B) Western blot analysis of the proteins from human RPE
immunoprecipitated with anti-Gai3 antibody. SDS–PAGE was followed by incubation with anti-OA1 antibody. Left lane: RPE extract incubated with
Gai3 antibody; right lane: RPE extract incubated with pre-immune serum. Two isoforms of OA1 have apparent molecular weights of 45 and 48 kDa
(arrowheads).
doi:10.1371/journal.pone.0024376.g005
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tions from RPE with PTX and
32P-nicotinamide adenine
dinucleotide (
32P-NAD), an autoradiography of the
32P-labeled
proteins separated on 6 M Urea-SDS-PAGE was obtained. Two
bands at 40 and 41 kDa corresponding to Gai2 and Gai1 plus
Gai3, respectively, were observed on the lane of the gel containing
the RPE from control mice (Figure 7A, lane 1). In contrast, the
RPE from Oa1-/- mice only showed the band corresponding to the
32P-ADP ribosylated Gai2. No sign of Gai3 or Gai1 was present
on the autoradiograph (Figure 7A, lane 2). To corroborate these
results, a Western blot was prepared with the same samples, using
the Gacommon antibody. Figure 7B shows the Gai2 and Gai1 plus
Gai3 bands in the control RPE (lane 1), but in Oa1-/- RPE,
comparable levels of Gai2 but a very minimal amount of either or
both Gai1 and Gai3 are seen (lane 2).
Discussion
We have previously demonstrated by in-vivo studies on mice that
the heterotrimeric G protein Gai3 signals in the same transduction
pathway controlled by Oa1 to regulate melanosomal biogenesis
and axonal growth through the optic chiasm [12]. However, the
interaction between Oa1 and the two other members of the Gai
family of proteins, Gai1 and Gai2, remained to be explored. In
this paper, taking advantage of the availability of knockout mice
for each of the Gai genes, and of DKO (Gai1-/-, Gai3-/-) mice, we
tested the hypothesis that Oa1 transmits its signal through one
specific Gai protein and demonstrated with in-vitro and in-vivo
experiments that this protein is indeed Gai3.
To investigate the involvement of all Gai proteins in the
regulation of size, density and shape of RPE melanosomes,
electron micrographs of the RPE from 3-month-old Gai1-/-,
Gai2-/-, Gai3-/-, DKO and 129 Sv were analyzed. With regard to
size, our results indicate that only the loss of function of Gai3
significantly increases the number of macromelanosomes in the
RPE. Even with loss of function of both Gai1 and Gai3, no added
effect in the size of DKO melanosomes was observed when
compared to melanosomes of Gai3-/- RPE, suggesting that Gai1 is
not involved in establishing the size of RPE melanosomes. We
then looked at the number of melanosomes per unit area of RPE,
and found that melanosomal density in Gai1-/- and Gai2-/- were
not significantly reduced from that in 129 Sv wild-type RPE.
Conversely, melanosomal density was reduced significantly and
similarly in Gai3-/- and in DKO RPEs when compared to wild-
type RPE. This again supports the notion that Gai1-/- does not
contribute to the RPE melanosomal density decrease observed in
DKO mice. We also established that despite the appearance of
fewer round melanosomes in Gai2-/- RPEs, there is not a major
change in the percent frequency of round melanosomes in all
Gai-/- RPEs when compared to those in the wild-type 129 Sv. In
addition, as demonstrated by electroretinography, the retinas of
Gai3-/- as well as those of DKO mice are functional despite the
phenotype of their RPEs (Figure 3A) similar to what was
previously observed in the ERG of Oa1-/- mice [12]. Thus, these
results together lead us to conclude that of the three heterotrimeric
Gai proteins, Gai3 is the Oa1-associated protein involved in the
regulation of RPE melanosomal size and density.
Potential binding sites for heterotrimeric G-proteins on GPCRs
have been localized to the cytoplasmic loop 3 (i3) and carboxy-
terminal tail (CT) of the seven-transmembrane receptors [14].
These intracellular segments are the ones that determine the
interaction with specific G proteins, and as a result, which of
several possible signaling pathways are activated [17,18,19,20].
Therefore, we generated GST-fusion proteins with the Oa1-i3 and
Oa1-CT segments and used them in GST pull-down assays to
determine which Gai protein bound in-vitro to Oa1. Results of
these experiments showed that of the three heterotrimeric Gai
proteins, Gai3 is the only one that binds specifically to Oa1. Most
important, immunoprecipitation of RPE proteins using Oa1
antibodies, followed by SDS-PAGE and mass spectrometry
analysis of the proteins, brought down Gai3 together with Oa1,
conclusively identifying Gai3 as an Oa1-specific interacting
protein. These results were further confirmed by immunoprecip-
itation experiments of RPE proteins using Gai3 antibodies, which
also demonstrated that Oa1 co-immunoprecipitated with Gai3.
Collectively, these data indicate that the GPCR Oa1 initiates in
the RPE the signal transduction cascade that controls melano-
somal size and density through activation of Gai3.
Compensatory increases elevating a Gai subunit level in a tissue
when another Gai subunit is missing from it have been previously
observed [16]. This raises the possibility that in the RPE of Gai
knockout mice, at the protein level, compensatory expression of
the other Gai subunits may reduce the effect that the loss of a
particular Gai protein has on the control of melanosomal size and
density. To test this, we measured the levels of the three Gai
proteins in the RPEs of Gai1-/-, Gai2-/-, Gai3-/- and DKO mice
using Western blotting with a Gaicommon antibody. Our results
suggest that at the protein level, only the loss of Gai1 from the
RPE may be compensated for by Gai3. However, with respect to
functional compensation of the melanosomal phenotype, we
cannot conclude that Gai3 functionally compensates for the loss
of Gai1 since our results show that Gai1-/- melanosomes are not
significantly different from those observed in control mice, even
though they are a bit larger. Similarly, the fact that the DKO
phenotype is no worse than that of Gai3-/- alone with respect to
size, density or shape of RPE melanosomes, suggests that Gai1 is
not critical for the regulation of these parameters. Furthermore,
compensatory increases, if any, in Gai1 protein in the Gai3-/-
retina seem to play no role in melanosome biogenesis. Although
Gai2 levels are considerably increased in the Gai1-/- animals and
to a quite lesser extent in Gai3 knockouts, we have shown in the in
vivo experiments that Gai2 is not involved in the determination of
melanosome size. Given the high levels of this protein in the RPE,
it must play an important, though different, role in this tissue than
Gai3, a role having quite discriminable effects, evidenced in the
ERG itself (Figure 3B).
ADP-ribosylation of Ga subunits is a covalent modification
catalyzed by PTX in which an ADP-ribose moiety is attached to
the C-terminus of the protein. This prevents the Gi proteins to
interact with their receptors and, therefore, it causes functional
inactivation of all signal transduction pathways. ADP-ribosylation
with NAD
32P-labeled on its ADP-ribose moiety allowed us to tag
Gai subunits in membranes and to learn about their involvement
in cellular responses. We carried out this reaction using RPE
membranes of Oa1-/- and their congenic B6/NCrl mice.
Interestingly, our results showed that the three Gai subunits are
present in the RPE of control mice, but that only Gai2 is in the
Oa1-/- RPE. Similarly, when we used samples from the same RPE
membranes to perform Western blotting with the Gacommon
antibody we found that Gia2 levels in -/- Oa1 RPE are
comparable to those in the control RPE, but that there is very
minimal, if any, amount of either or both Gai1 and Gai3 in the
Oa1-/- RPE. These interesting results will lead to a whole series of
studies in the future.
It is well established that in addition to their important roles in
many pathways of transmembrane signaling, where they partic-
ipate in processing and sorting of incoming signals as well as in
adjusting the sensitivity of the signaling system, heterotrimeric G-
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are involved in the formation of secretory vesicles from the trans-
Golgi network (TGN) [9]. Gai3, in particular, acts as an inhibitor
of intra-Golgi and post-Golgi trafficking [22], and has been found,
among other places, in the membranes of secretory vesicles in
pancreatic acinar cells, from where it facilitates the fusion between
zymogen granules and/or the expulsion of vesicular contents [23].
The specific function of Gai3 in the RPE has not been
identified. Our working hypothesis is that after the bulk of Oa1,
together with tyrosinase, TRP1 and other compounds involved in
melanin synthesis, has reached the stage II melanosomes, Oa1
starts to activate Gai3, which in turn inhibits the traffic of vesicles
carrying the membrane proteins required for melanization from
the TGN. However, melanization occurs with no problem in stage
III and IV melanosomes, as they use the proteins already present.
This would explain why the levels of Oa1 decrease from those in
stage II melanosomes to those in stages III and IV [24]. Oa1 is not
being renewed in the melanosomes after its activation of Gai3
because there are no longer vesicles bringing this protein to the
melanosomes. Thus, the function of Gai3 in the RPE would be to
control the size of melanosomes through the inhibition of vesicle
trafficking from the TGN to the melanosome, a function
previously thought to be carried by Oa1 [25].
On the basis of our results and the accumulated information in
the literature about GPCRs, Gai3 functions and melanogenesis,
we are proposing a hypothetical model for the beginning of the
Oa1 signaling cascade (Figure 8A).
In this model, at the end of stage II melanogenesis, when
melanosomes have acquired their melanogenic proteins and the
bulk of Oa1, a signal must turn on an endogenous lumenal ligand
to activate Oa1 at the melanosomal surface membrane. Like in
other GPCR cascades, activated Oa1 will cause the exchange of
GDP for GTP on the Gai3 subunit of the heterotrimeric G protein
localized to the surface of the same membrane, activating Gai3
(Gai3*) –which then separates from the bc subunits– and leading
to the release of Gai3* and Gbc to the RPE cytoplasm. Gai3* will
at this stage inhibit the vesicular traffic of membrane proteins from
the TGN to the melanosome. Prenylation of the Gc subunit will
target the Gbc complex to the endoplasmic reticulum, where it
will be processed fully before it is delivered to the Golgi. There,
Gbc will bind Gai3 and after post-translational modification of
Gai3, the G protein heterotrimer may leave the TGN and get
transported to the melanosome surface membrane using the classic
secretory pathway.
This model could also explain the presence of macromelano-
somes in the RPE of ocular albinism patients or Oa1 and Gai3-/-
mice (Figure 8B). Mutations in the OA1 gene in humans could
render the OA1 protein incapable of activating the heterotrimeric
Gai3 on the surface membrane of the melanosome. The same
effect would be observed in the absence of Oa1 or Gai3 in
knockout mice. Without the active form of Gai3*, inhibition of the
vesicular traffic of melanin-related proteins to stage II melano-
somes cannot occur, and the continuous supply of this material to
the melanosome would result in the formation of abnormally large
organelles, the macromelanosomes.
In summary, while the precise function of Gai3 in RPE
melanosome biogenesis remains to be delineated, it is clear that
this protein plays an important role in the control of the size of
RPE melanosomes. As a consequence, Gai3 is also controlling
RPE pigmentation, which seems to be necessary during embryonic
stages for the proper decussating pattern of the optic axons.
Because Gai3-/- mice, like Tyr-/- and Oa1-/- mice, all show
abnormalities in the decussation of their optic axons [12], Gai3
appears to be the common effector by which these three distinct
RPE phenotypes affect the retinal ganglion cells as their axons
navigate the optic chiasm.
Materials and Methods
Ethics Statement
All experiments involving mice were carried out using protocols
approved by the UCLA Animal Research Committee, and in
accordance with the ARVO Statement for Use of Animals in
Ophthalmic and Vision Research.
Animal and human tissues
C57BL/6NCrl (B6/NCrl) mice and congenic Oa1 knock-out
mice (Oa1-/-) were obtained from The Charles River Labs, USA
and Italy, respectively, and bred at UCLA. Gai1-/-,G ai2-/-,
Gai3-/- and the DKO mice were previously generated on the
129 Sv background. The genotype of these mice was determined
by Southern blot analysis of mouse tail genomic DNA as described
by Jiang et al. [26]. Mice were housed and bred in conventional
cages and environmental conditions at the animal facilities of
UCLA.
Figure 6. Western blot of RPE proteins from all Gai-/- mice
using an anti- Gacommon antibody. A) RPE membrane proteins from
3-month-old mice were separated by SDS-PAGE, blotted and reacted
with Gacommon antibodies. Protein bands were visualized using the ECL
detection reagent. The RPE proteins are from: Gai1-/- (lane 1), Gai2-/-
(lane 2), Gai3-/- (lane 3), DKO (lane 4) and 129 Sv (lane 5) mice. The
membrane was then stripped and reacted with a-tubulin antibodies to
confirm that the amount of protein loaded on each lane was the same.
B) Analysis of the immunoblot by densitometry using the Quantity One
1-D Software. Numbers represent the optical density units per mm
2 (OD
U/mm
2) of each Gai protein band.
doi:10.1371/journal.pone.0024376.g006
Figure 7. ADP-ribosylation of Gai proteins and Western blot of
Oa1-/- and control B6/NCrl RPE proteins. A) RPE membrane
proteins from 3-month-old mice were subjected to
32P-ADP ribosylation
with PTX, separated by SDS-PAGE and visualized by autoradiography.
Lane 1: control B6/NCrl RPE; lane 2: Oa1-/- RPE. B) Western blot using
the same RPE membrane proteins separated by SDS-PAGE and reacted
with the Gacommon antibody. Lane 1: B6/NCrl RPE and lane 2: Oa1-/- RPE.
doi:10.1371/journal.pone.0024376.g007
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24376Healthy human donor eyes were obtained from the National
Disease Research Interchange (Philadelphia, PA) and immediately
frozen in liquid nitrogen. The donor eyes were handled in
compliance with the Declaration of Helsinki.
Electron Microscopy
3 month-old 129 Sv, Gai1-/-,G ai2-/-, Gai3-/- and DKO mice
were deeply anesthetized by an intraperitoneal injection of
120 mg/kg sodium pentobarbital, and perfused intracardially
with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M
sodium phosphate buffer, pH 7.4. Eyes were enucleated, rinsed in
0.1 M phosphate buffer, post-fixed with 1% buffered osmium
tetroxide, dehydrated in graded ethanol, and embedded in araldite
502. Sections for electron microscopy (60–70 nm) were cut on a
Leica Ultracut UCT and collected on 200 mesh uncoated copper
grids. For the ultrastructural analysis, stained sections (5% uranyl
acetate and 0.4% lead citrate) were observed with a 910 Zeiss
electron microscope. The RPE fields analyzed were photographed
using a Keenview
TM digital camera. For quantification of
melanosomes and determination of their area in the RPE, we
analyzed 50 micrographs for each 129 Sv and DKO mice and 30
micrographs for each Gai1-/-, Gai2-/- and Gai3-/- mice at
16,0006 magnification using the analySIS
TM software for LEO
900 TEM, version 3.2. (Soft Imaging System, Lakewood, CO).
Images were cropped with Adobe Photoshop (Adobe Systems Inc.,
San Jose, CA). A total of 2501 129 Sv, 1285 Gai1-/-, 1609
Gai2-/-,1115 Gai3-/- and 1997 DKO melanosomes were studied,
sampling 10 eyes for each 129 Sv and DKO mice and 6 eyes for
each Gai1-/-, Gai2-/- and Gai3-/- mice. The data for the Gai3-/-
mice were previously reported, but are included herein for direct
comparison.
Melanosomal size and density. We used the magic wand
feature of the Soft Imaging System analySIS software to select and
measure the area of every individual melanosome and of the total
RPE area containing the melanosomes in each micrograph, as we
have done previously in the analyses of Gai3-/- and the Oa1-/-
mice and their corresponding controls [12]. We analyzed the
difference in the melanosomal size, the percent frequency of
melanosomes in the .5000 nm
2 size range, and the number of
melanosomes per RPE area among five mouse groups: 129 Sv,
Gai1-/-, Gai2-/- and Gai3-/- and DKO. Comparisons among all
groups were done using a one way analysis of variance (ANOVA)
followed by post-hocTukey tests to identify significant differences
between individual pairs of groups, conservatively using animal
averages for each measure and thus an n of 5 for the 129 Sv and
DKO groups and an n of 3 for the Gai1-/-, Gai2-/- and Gai3-/-
groups. A p-value of less than 0.05 was considered to be
statistically significant.
Melanosomal Morphology. To determine melanosomal
shape we used the particle detection analysis of the Soft Imaging
System analySIS software for LEO 900 TEM, version 3.2. The
classification of the shape of the organelles is given by how round
the organelle is. A melanosome with a shape factor of 1 is round,
while elliptical melanosomes have a shape factor less than 1. We
compared the percentage of round melanosomes for each
particular mouse line. The differences among all mouse groups
[129 Sv, Gai1-/-, Gai2-/-, Gai3-/- and DKO] were compared
using one-way ANOVA and post-hoc Tukey tests, all as above.
Electroretinography
Mice were anesthetized with an intraperitoneal injection of
xylazine (0.5 mg/ml) and ketamine (1 mg/ml) in normal saline. In
adult mice, a dose of 0.1 ml was administered. Body temperature
was maintained at 38uC with a heating pad. Pupils were dilated
with Atropine (1%). A gold-wire electrode was placed on the
corneal surface of the right eye and referenced to a gold wire in the
mouth. A needle electrode in the tail served as the ground.
Responses were amplified (Tecktronix AM 502 Differential
Amplifier, 610,000) band pass filtered (0.1–300 Hz), digitized
using an I/O board (PCI-6221, National Instruments, Austin, TX)
in a personal computer, and averaged. A signal rejection window
was used to eliminate electrical artifacts. All stimuli were presented
in a large integrating sphere painted with a highly reflective white
matte paint (#6080, Eastman Kodak Corporation, Rochester,
NY). Rod mediated responses were obtained with blue flashes
(Wratten 47A; Imax=470 nm) varied over an intensity range of 3.5
log units. Cone-mediated responses were obtained with white
flashes on a rod saturating background (32 cd/m
2).
Production of GST::OA1-i3 and GST::OA1-CT recombinant
proteins
Mouse Oa1 cDNA was subcloned into the mammalian
expression vector pCDNA3.1/V5-His-Topo using EcoRI and
PstI sites in the polylinker. Using this construct, a 108 bp DNA
fragment corresponding to the third cytosolic loop (i3) of OA1
(residues 213–248), with flanking fragments corresponding to the
BamHI and SalI restriction enzymes, was amplified by PCR using
the following primers: Forward, 59-TGGA TCCTTTCACAA-
GACAGTGACTTCA-39; and Reverse, 59-AGTCGACTCAT-
TTG AAAAAACGGGTCTTGAT-39. Similarly, a 275 bp DNA
fragment corresponding to the C terminal (CT) of OA1 (residues
314–405), with flanking fragments corresponding to the BamHI
and SalI restriction enzymes, was amplified by PCR using the
following primers: Forward, 59-TGGATCCACAGGATG-
CAGCCTGGATGTC-39; and Reverse, 59-AGTCGACTCA-
GAGTTCCCCCTGGGCTTGGGA-39. The 25 ml reaction con-
tained 2.5 mg of each 59 primer and 39 primer, 100 ng/ml
pCDNA3.1/V5-His-Topo–OA1, 0.6 Units of Taq DNA poly-
merase (Invitrogen Corporation, Carlsbad, CA), 16PCR buffer,
2.5 mM MgCl2 and 250 mM dNTP mix. After 30 cycles (melting
for 3 min at 94uC; annealing for 1.5 min at 53uC; extension for
1 min at 72uC), the PCR reactions were subjected to an additional
5 min incubation at 72uC. Each PCR reaction yielded a single
product that was subsequently isolated and gel purified, cut with
BamHI and SalI, and subcloned into the pGEX-4T-2 vector
(Amersham Bioscience, now GE Healthcare, Piscataway, NJ)
using T4 ligase. Ligation reactions were used for transformation of
BL21 (DE3) E. coli, and were selected on LB-ampicillin agar plates.
Positive clones were screened by restriction analysis and DNA
sequencing.
Preparation of GST-Fusion Proteins
E. coli cultures carrying the pGEX-4T-2 constructs were grown
until they reached mid-logarithmic growth phase (0.4–0.5 A600).
Isopropyl-b-D-thiogalactopyranoside (IPTG) was then added to a
final concentration of 0.1 mM to induce GST protein expression,
and the cultures were further incubated for 4 h at 30uC. GST was
Figure 8. Proposed hypothetical model of the Gai3 regulation of RPE melanosomal size. A) An unknown luminal ligand (L?) turns on wild-
type Oa1, which activates Gai3. The active Gai3 in turn inhibits vesicular traffic of proteins from the TGN to the melanosome, controlling in this way
its size. B) Mutated OA1 is unable to activate Gai3 and, thus, the continuous supply of melanin-related proteins to the melanosome results in the
formation of very big organelles, the macromelanosomes.
doi:10.1371/journal.pone.0024376.g008
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i3 fusion protein was obtained as previously described [27] with
few modifications. Briefly, bacteria were harvested by centrifuga-
tion at 4,000 g for 15 min and the pellets were resuspended in
2 ml of STE Buffer (10 mM Tris, pH 8.0, 150 mM NaCl, 1 mM
EDTA, 25 mg/ml PMSF and protease inhibitors cocktail)
containing 50 mg/ml of lysozyme (added immediately prior to
resuspension), and incubated on ice for 15 min. Dithiothreitol
(DTT) was then added to a final concentration of 2.5 mM.
Bacteria were lysed by the addition of 1.0% N-lauroylsarcosine
(Sarkosyl), disrupted on ice for 1 min using a MISONIX Sonicator
3000 (power level 3, 50% cycle) and centrifuged at 13,000 g for
10 min at 4uC to remove insoluble debris. To obtain the
GST::Oa1-CT fusion protein, a similar procedure was followed,
but no lysozyme or Sarkosyl was used.
Purification of GST-tagged proteins
GST-tagged proteins were purified from bacterial lysates by
affinity chromatography using immobilized Glutathione Sephar-
ose
TM High Performance (GE Healthcare). 1 ml GSTrap HP
column was equilibrated with 5 ml of binding buffer (PBS, pH 7.3)
and 1 ml of bacterial lysate was loaded onto it. The column was
washed with 5 ml of binding buffer and the GST-tagged protein
was eluted with 3 ml of elution buffer (50 mM Tris-HCL, 10 mM
reduced glutathione, pH 8.0).
GST activity assay
The GST specific activity was measured spectrophotometrically
using the GST assay kit (Sigma-Aldrich Corporation, St. Louis,
MO) according to the manufacturers’ instructions, using 1 mM 1-
chloro-2,4-dinitrobenzene (CDNB) and 2 mM reduced-glutathi-
one (GSH) as substrates at 340 nm and 25uC. Fractions with good
GST activity (,600–800 mg/ml) were used for incubations with in-
vitro transcribed/translated
35S-methionine-labeled Ga proteins
(see below).
In-vitro synthesis and
35S-methionine-labeling of Ga
Proteins
Gai1, Gai2, Gai3, Gas and Gaq were in-vitro transcribed,
translated and labeled with
35S-methionine using the pAGA-2
vector containing the cDNA of the corresponding Ga protein and
the TNT Coupled Reticulocyte Lysate system (Promega, Madison,
WI) with T7 RNA polymerase. The resulting
35S-labeled proteins
(1.5 mg of each) were boiled in 26 SDS–PAGE sample buffer
containing 3% b-mercaptanol, loaded onto a 10% Tris-Glycine
gel and electrophoresed at 45 V until the dye had run out of the
gel. After washing with water for 10 min (3 times), and immersing
in 5% glycerol for 15 min, the gel was dried and visualized by
autoradiography. The relative expression of
35S-labeled Ga
proteins was analyzed by densitometric measurement using
Quantity One 1-D analysis software (version 4.4, Bio-Rad,
Hercules, and CA). The mean density for each band, expressed
as number of pixels, was used to calculate the ratio of each protein
to the
35S-labeled Ga protein that had the lowest number of pixels
(ratio=1). This number was used to determine the appropriate
volume of each
35S-labeled Ga protein that was used for the GST-
pull down assay.
GST-pull-down assays
For in-vitro protein-protein interaction assays, 10 ml of each
35S-
Ga-protein expressed from the pAGA-2 vector containing the
same amount of protein were incubated with 50 ml of Immobilized
Glutathione agarose resin (Thermo Fisher Scientific Inc., Wal-
tham, MA), ,1 mg of GST protein or the GST-fusion protein
(GST::Oa1-i3 or GST::Oa1-CT), and 100 ml of Binding buffer
(50 mM Tris, pH 7.5, 100 mM NaCl, 0.5% Triton 1006) for 2 h
at room temperature (RT). The beads were recovered by
centrifugation at 3,000 g, 4uC, for 1 min, washed for 5 min (5
times) with 500 ml of ice-cold Binding buffer, and centrifuged
again for 1 min at 8,000 g. The protein-protein interacting
complex was eluted from the beads with 30 mlo f2 6SDS–PAGE
sample buffer containing 3% b-mercaptanol and its components
were separated by SDS-PAGE as above, on a 10% Tris-glycine
gel. The gel was fixed and Coomassie blue-stained to confirm that
the fusion proteins were present in comparable amounts and had
the right molecular weight. After destaining, the gel was dried and
exposed to X-ray film overnight (280uC) to visualize the
interacting
35S-Ga-proteins.
Mass Spectrometry Analysis
Several steps were followed to prepare samples for mass
spectrometry:
Immunoprecipitation and Western Blotting. Normal
human RPE was dissected from frozen donor human eyes. Tissue
washomogenized on icewith a Dounce homogenizer in 500 mlR I PA
lysis buffer containing 50 mM Tris–HCl pH 7.5, 150 mM NaCl,
0.5% Na-deoxycholate, 0.1% SDS, 1 mM PMSF, 16 complete
protease inhibitor cocktail (Roche Molecular Biochemicals,
Indianapolis, Indiana), and 5 mM N-ethylmaleimide (Sigma-
Aldrich Corporation). Homogenates were pre-cleared with 100 ml
of protein G–Sepharose (Thermo Fisher Scientific, Inc.) for 1 h at
4uC. Lysates (500 ml) were first incubated with 17 mlo fa n t i - O A 1
(ABCAM, Cambridge, MA) or with 17 mla n t i - G ai3 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) rabbit polyclonal primary
antibodies, at 4uC overnight, and then with 50 mlo fp r o t e i nG –
Sepharose for 2 h at RT. The complex-bound resin was washed 5
times with IP buffer (25 mM Tris–HCl, 150 mM NaCl; pH 7.2) and
3 times with water. Immunoprecipitated complexes were eluted with
26 SDS–PAGE sample buffer containing 3% b-mercaptanol and
each of duplicate aliquots were loaded onto a different half of a 12%
Tris-glycine gel. SDS-PAGE was carried out overnight at 44 V. Half
of the gel was stained with Coomassie blue to visualize protein bands
for mass spectrophotometry analysis and the other half was
transferred to a nitrocellulose membrane (Hybond ECL,
Amersham Biosciences) overnight at 33 V. The blot was then
incubated with 1:10,000 anti-Gai3 or anti-OA1 rabbit primary
antibodies, and with 1:10,000 goat anti-rabbit secondary antibodies.
The Enhanced Chemiluminescence (ECL) detection reagent
(Amersham Biosciences) was used to visualize the bands.
Tryptic Digestion. Protein bands of interest on the
Coomassie blue–stained gel were excised and placed in
microtubes. In-gel digestion with trypsin was performed
according to standard procedures routinely used in the Pasarow
Mass Spectrometry core facility at UCLA. Briefly, the gel pieces
were distained with 10 ml acetonitrile (ACN) for 30 min at RT and
treated with 10 mM DTT/100 mM NH4HCO3 (200 ml) for
1 hour at 37uC. Samples were then alkylated with 55 mM
iodoacetamide (Sigma-Aldrich Corporation). The gel pieces were
washed with 100 mM NH4HCO3 for 15 min at RT, dehydrated
with ACN and digested with 1.25 mg trypsin (Promega) in 100 ml
of 50 mM NH4HCO3, on ice, for 45 min. They were then
incubated overnight in 10 mlo f5 0 m MN H 4HCO3, without
trypsin. The digests were extracted twice with 100 ml of 50%
ACN/0.5% formic acid at RT for 60 min with constant mixing,
the extracts were pooled and dried and each sample was
then reconstituted with 8 ml of 2% formic acid and sent for
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MSMS) analysis at the Pasarow core facility.
Database Analysis. The mass spectra weresearched against a
human trypsin indexed database, with variable modifications of
carboxyamidomethylation, methionine oxidation, and deamination
of asparagine residues using the Bioworks software (Thermo Fisher)
based on the SEQUEST algorithm implemented in Discoverer
software (Thermo Fisher). Spectra were also searched using Mascot
software (Matrix Science, UK) and results with p,0.05 (95%
confidence interval) were considered significant and indicating
identity.
Preparation of RPE Membranes
The RPEs from Gai1-/-, Gai2-/-, Gai3-/-, DKO, Oa1-/- and
their corresponding 129 Sv and B6/NCrl control mice (12 eyes of
each), were dissected, collected and frozen in liquid nitrogen. Each
sample was homogenized in 250 ml of 27% (wt/wt) sucrose/1 mM
EDTA/10 mM Tris?HCl, pH 7.5, in Dounce homogenizers.
Homogenates were centrifuged for 5 min at 1,000 g and the
supernatants were again centrifuged at 12,000 g for 20 min to
obtain the RPE membranes. Quantification of protein from
melanin-containing RPE membranes was carried out by the
method of Sedmak and Grossberg, which depends on the
conversion of Coomassie brilliant blue G-250, in diluted acid,
from a brownish-orange to an intense blue color [28]. With this
very sensitive method the melanin interference is negligible. The
G-250 dye was prepared as a 0.06% solution in 19% perchloric
acid (w/v) and was filtered through Whatman No. 1 filter paper to
remove any undissolved material. The assay consisted of adding
0.5 ml of the G-250 dye to 5 ml of homogenized RPE membranes,
mixing immediately, and determining absorbance at 620 nm.
Western blot analysis
The Gai1, Gai2,and Gai3 protein levelsinRPEmembranes from
129 Sv, Gai1-/-, Gai2-/-, Gai3-/- and DKO mice, were measured
using an anti-Gacommon antibody (Cell Signaling technology,
Danvers, MA) that recognizes all the Gaia n dG ao proteins. Proteins
(15 mg per lane) were separated by SDS-PAGE as above on 9%
acrylamide/bis-acrylamide gels containing 6 M urea and blotted
onto nitrocellulose. Blots were incubated with 1:2,000 anti-Gacommon
polyclonal anti-rabbit primary antibody, overnight, at 4uCa n dw i t h
1:5,000 goat anti-rabbit secondary antibody for 3 hours at RT. The
ECL detection reagents were used to visualize the bands.
ADP ribosylation of Gai proteins
Using the membrane proteins from B6/NCrl and Oa1-/- mice we
performed ADP-ribosylation as described in Jiang et al. [29,30]. The
reaction mixture (30 ml) contained 15 mM Tris-HCl, pH 8.0, 1 mM
EDTA, 10 mM thymidine, 1 mM ATP, 1 mM guanosine 59-0-(2-
thiodiphosphate) (GDPbS), 2 mM dithiothreitol, 0.17% Lubrol PX,
0.02% bovine serum albumin, 10 mg/ml PTX activated by DTT
(50 mM), 5610
6 cpm
32P-NAD (,2610
6 M) and 15 mgp r o t e i no f
crude RPE membranes. The mixture was incubated at 4uC
overnight. The reaction was stopped by addition of 10 mlo fc o m p l e t e
26Laemmli’s sample buffer containing 9% b-mercaptoethanol and
4 mM unlabeled NAD. The ADP-ribosylated proteins were
separated by high resolution urea-SDS-PAGE (9% acrylamide/bis-
acrylamide gel containing 6 M urea), overnight, at 44 V. The gel was
dried and autoradiographed. Expected bands were observed at
41 kDa for the Gai1 and Gai3 and at 40 kDa for the Gai2ribosylated
proteins.
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